Drugs of abuse Flashcards
opiate reinforcing effects
euphoria, analgesia, sedation with anxiety reduction
opiate CNS action
interferes with endogenous mu opioid recepors
histamine release –> “rush” feelings
CNS depressants reinforcing effects
euphoria, sedation, anxiolytic, body building effects (GHB)
CNS depressant action
enhanced GABA activity
barbiturates and ETOH at high doses –> decreased glutamate
GHB –> complex effects at brain DA systems
CNS stimulant action
block catecholamine (esp DA) reuptake, increased catecholamine release
CNS stimulant reinforcing effects
elevation of mood, feeling of exhilaration, sense of increased energy and alertness, decreased fatigue and need for sleep, decreased appetite
Nicotine CNS action
nicotinic neuronal receptor agonist
Nicotine reinforcing effect
mild alerting effect
Hallucinogens CNS action
agonist at 5HT2 postsynaptic serotonin receptors
Hallucinogens reinforcing effects
altered perception, mood elevation, dissociation from self
Marijuana CNS action
cannabinoid receptor agonist (CB1) –> increased dopamine release in nucleus accumbens
Marijuana reinforcing effects
euphoria; changes in mood, perception and motivation
anticholinergic CNS action
block muscarinic cholinergic receptors
anticholinergic reinforcing effects
mood elevation, hallucinations, delirium
inhalants CNS action
general CNS depression via altered membrane permeability –> altered GABA/DA neurotransmission
inhalants reinforcing effects
euphoria, giddiness, dizziness, lightheadedness, disinhibition, floating sensation, misperception, clouding of thoughts
dissociative anesthetics CNS action
NMDA receptor antagonist. blocks reuptake of DA and serotonin. increased DA release in limbic and cortical structures
dissociative anesthetics reinforcing effects
lower dose: floating feeling of euphoria and heightened emotionality
Intermediate dose: increased talkativeness, misperceptions of sensory input, feelings of unreality, changes in body image
higher doses: hostile/bizarre behavior
opioid toxicity and treatment
toxic symptoms: coma, respiratory distress, pinpoint pupils, arrhythmias, parkinson-like effects (MPTP)
Treatment: establish airway, stabilize cardiopulmonary status. Naloxone (can lead to withdrawal in dependent addicts)
CNS depressant toxicity and treatment
Toxicity: confusion, emotional lability, ataxia, hyporeflexia, miosis.
severe = respiratory depression and hypotension –> coma and death
Treatment: supportive measures. Flumazenil (benzo OD). Respiratory support, IV glucose, thiamine, multivitamins, K, MG (ETOH OD)